Skip to content

AYURVEDIC MANAGEMENT OF CEREBRAL PALSY IN CHILDREN.

THERAPEUTIC EFFECT OF KALYANAKA AVLEHA & KARMA BASTI IN THE MANAGEMENT OF SPASTIC CEREBRAL PALSY IN CHILDREN - A SINGLE ARM OPEN ENDED CLINICAL STUDY

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/07/034864
Enrollment
30
Registered
2021-07-15
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F079- Unspecified personality and behavioral disorder due to known physiological condition

Interventions

Intervention1: Kalyanak Avleha & KARMA BASTI: will be given in a dose 1mg/kg/day in two divided doses as per Young Formula While Anuvasan Basti & Karma Basti will be given as per Kashyapa Samhita Cont

Sponsors

Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University Jodhpur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Children are of age group one to sixteen years of either sex. â?? Diagnosed case of Spastic Cerebral palsy will be selected.

Exclusion criteria

Exclusion criteria: Children below 1 year and above 16 year of age will be excluding from the study. â?? Children suffering from any progressive neurologic disorders such as meningitis, encephalitis will be excluded from study. â?? Children suffering from various disorders like myopathies, neuropathies, juvenile diabetes mellitus, essential hypertension and any acute respiratory distress will be excluded from study.

Design outcomes

Primary

MeasureTime frame
1. Reducing in spasticity and Increasing quality of life.Timepoint: Improvement of spasticity and quality of life in 90 days

Secondary

MeasureTime frame
IMPORVEMENT OF HEALTH STATUSTimepoint: 90 DAY

Countries

India

Contacts

Public ContactDr Harish Kumar Singhal

DR.Sarvepalli Radhakrishnan Rajasthan Ayurved University

drharish_md@yahoo.co.in9636622206

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026